We did a global review to synthesise data on the prevalence, harms, and interventions for
stimulant use, focusing specifically on the use of cocaine and amphetamines. Modelling …

This paper summarises data for the prevalence, correlates, and probable adverse health
consequences of problem use of amphetamines, cannabis, cocaine, and opioids. We …

Background No systematic attempts have been made to estimate the global and regional
prevalence of amphetamine, cannabis, cocaine, and opioid dependence, and quantify their …

Aims To estimate the global prevalence of cocaine and amphetamine dependence and the
burden of disease attributable to these disorders. Methods An epidemiological model was …

We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

We assess the current and describe possible future public health impacts of the legalisation
of cannabis production, sale, and use in the Americas. First, we describe global patterns of …

Amphetamine-group substances are used worldwide and are more prevalent than either
cocaine or opioids. We reviewed published reports about amphetamine-group substances …

The burden of mental, neurological, and substance use (MNS) disorders increased by 41%
between 1990 and 2010 and now accounts for one in every 10 lost years of health globally …

Abstract Introduction The Global Burden of Disease (GBD) 2010 study updated the findings
of earlier exercises. It provided regional and global estimates of the burden of disease …

The citizens of four US states—Alaska, Colorado, Oregon, and Washington—have voted to
legalise the sale of cannabis to adults for recreational purposes, and more states look likely …